Cargando…

Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease

PURPOSE OF REVIEW: This review offers a critical narrative evaluation of emerging evidence that sodium-glucose co-transporter-2 (SGLT2) inhibitors exert nephroprotective effects in people with type 2 diabetes. RECENT FINDINGS: The SGLT2 inhibitor class of glucose-lowering agents has recently shown b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailey, Clifford J., Day, Caroline, Bellary, Srikanth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Microvascular Complications—Nephropathy (B Roshanravan, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888485/ https://www.ncbi.nlm.nih.gov/pubmed/35113333 http://dx.doi.org/10.1007/s11892-021-01442-z

Ejemplares similares

Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease
por: Hasegawa, Sho, et al.
Publicado: (2021)

New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

The Landscape of Diabetic Kidney Disease in the United States
por: Duru, O. Kenrik, et al.
Publicado: (2018)

Physical Activity in the Prevention of Development and Progression of Kidney Disease in Type 1 Diabetes
por: Pongrac Barlovic, Drazenka, et al.
Publicado: (2019)

An Update on the Use of Animal Models in Diabetic Nephropathy Research
por: Betz, Boris, et al.
Publicado: (2016)

MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
por: Simpson, Kate, et al.
Publicado: (2016)

Microvascular changes at different stages of chronic kidney disease
por: Kannenkeril, Dennis, et al.
Publicado: (2020)

Changes in metformin use in chronic kidney disease
por: Imam, Talha H.
Publicado: (2017)

Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease
por: Edwards, Marie E, et al.
Publicado: (2018)

MYH9-related disorders display heterogeneous kidney involvement and outcome
por: Tabibzadeh, Nahid, et al.
Publicado: (2018)

A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis
por: Imai, Eri, et al.
Publicado: (2016)

Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris
por: Beck, Sascha, et al.
Publicado: (2021)

Microvascular Angina: Diagnosis and Management
por: Aldiwani, Haider, et al.
Publicado: (2021)

Podocyturia: why it may have added value in rare diseases
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2018)

New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
por: Mignani, Renzo, et al.
Publicado: (2018)

Will the FAbry STabilization indEX make its way to everyday clinical practice?
por: Cairns, Tereza, et al.
Publicado: (2018)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy
por: Fernandez-Prado, Raul, et al.
Publicado: (2019)

A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy
por: Tziastoudi, Maria, et al.
Publicado: (2017)

Familial vasculitides: granulomatosis with polyangitis and microscopic polyangitis in two brothers with differing anti-neutrophil cytoplasm antibody specificity
por: Prendecki, Maria, et al.
Publicado: (2016)

Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018)

Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
por: Everett, Lesley A., et al.
Publicado: (2021)

The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment
por: Ahmed, Ishrat, et al.
Publicado: (2021)

Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy
por: Sachdeva, Mira M.
Publicado: (2021)

Renal toxicities associated with pembrolizumab
por: Izzedine, Hassan, et al.
Publicado: (2018)

Pembrolizumab-related renal toxicities: diagnosis first, treatment later
por: Sprangers, Ben
Publicado: (2018)

Oxalate nephropathy is a major cause of kidney injury in surgically treated pancreatic adenocarcinoma patients
por: Desbuissons, Geoffroy, et al.
Publicado: (2019)

The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
por: Chen, Hai Yong, et al.
Publicado: (2011)

Associations between sex and incident chronic kidney disease in a prospective diabetic cohort
por: Yu, Margaret K, et al.
Publicado: (2015)

Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?
por: Himeno, Tatsuhito, et al.
Publicado: (2018)

Painful and Painless Diabetic Neuropathies: What Is the Difference?
por: Shillo, Pallai, et al.
Publicado: (2019)

Molecular Aspects in the Potential of Vitamins and Supplements for Treating Diabetic Neuropathy
por: Okdahl, Tina, et al.
Publicado: (2021)

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
por: Saulnier, Pierre-Jean, et al.
Publicado: (2016)

Cholecystokinin Plays a Novel Protective Role in Diabetic Kidney Through Anti-inflammatory Actions on Macrophage: Anti-inflammatory Effect of Cholecystokinin
por: Miyamoto, Satoshi, et al.
Publicado: (2012)

Catalase Overexpression Prevents Nuclear Factor Erythroid 2–Related Factor 2 Stimulation of Renal Angiotensinogen Gene Expression, Hypertension, and Kidney Injury in Diabetic Mice
por: Abdo, Shaaban, et al.
Publicado: (2014)

Nitrite Anion Therapy Protects Against Chronic Ischemic Tissue Injury in db/db Diabetic Mice in a NO/VEGF-Dependent Manner
por: Bir, Shyamal C., et al.
Publicado: (2014)

Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018)

Clinical features and outcomes in a cohort of patients with immunoglobulin G4-related disease at a university hospital in Spain
por: Quero, Maria, et al.
Publicado: (2019)

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy
por: Kabeer, Muhammad Asif, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0a1ulc6g74kgjc77o6c4v3pp1j